Abstract
Eye is the most accessible and easily visualized organ in the human body; due to this feature ophthalmic dyes have a significant role in ophthalmology to aid effective diagnosis of ocular condition. These dyes are extensively used for the differential diagnosis in various ocular pathological conditions such as corneal abrasions, congestion, micro aneurysm, blood vessel proliferations in retina and ischemia etc.This chapter discusses about the handful of dyes such as trypan blue, rose bengal, indocynine green, brilliant blue, lissamine green and triamicolone actetonide etc., for their clinical utility, and their adverse effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Benedetto DA, Clinch TE, Laibson PR. In vivo observation of tear dynamics using fluorophotometry. Arch Ophthalmol. 1984;102:410–2.
Berkowitz BA, Tofts PS, Sen HA, Ando N, de Juan Jr E. Accurate and precise measurement of blood-retinal barrier breakdown using dynamic Gd-DTPA MRI. Invest Ophthalmol Vis Sci. 1992;33(13):3500–6.
Bert RJ, Caruthers SD, Jara H, et al. Demonstration of an anterior diffusional pathway for solutes in the normal human eye with high spatial resolution contrast-enhanced dynamic MR imaging. Invest Ophthalmol Vis Sci. 2006;47:5153–62.
Björnsson OG, Murphy R, Chadwick VS. Physicochemical studies of indocyanine green (ICG): absorbance/ concentration relationship, pH tolerance and assay precision in various solvents. Experientia. 1982;38(12):1441–2.
Brown SM, Graham WA, McCartney DL. Trypan blue in pediatric cataract surgery. J Cataract Refract Surg. 2004;30(10):2033.
Chang YS, Tseng SY, Tseng SH. Comparison of dyes for cataract surgery. Part 2: efficacy of capsule staining in a rabbit model. J Cataract Refract Surg. 2005;31(4):799–804.
Chang YS, Wu CL, Tseng SH, et al. Cytotoxicity of triamcinolone acetonide on human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2007;48(6):2792–8.
Couch SM, Bakri SJ. Use of triamcinolone during vitrectomy surgery to visualize membranes and vitreous. Clin Ophthalmol. 2008;2(4):891–6.
Emran N, Sommer A. Lissamine green staining in the clinical diagnosis of xerophthalmia. Arch Ophthalmol. 1979;97:2333–5.
Engel E, Schraml R, Maisch T, et al. Light-induced decomposition of indocyanine green. Invest Ophthalmol Vis Sci. 2008;49(5):1777–83.
Feenstra RPG, Tseng SCG. Comparison of fluorescein and rose Bengal staining. Ophthalmology. 1992;99:605–17.
Floman N, Zor U. Mechanism of steroid action in ocular inflammation: inhibition of prostaglandin production. Invest Ophthalmol Vis Sci. 1977;16(1):69–73.
Gandorfer A, Haritoglou C, Kampik A, Charteris D. Ultrastructure of the vitreoretinal interface following removal of the internal limiting membrane using indocyanine green. Curr Eye Res. 2004;29(4–5):319–20.
Hamrah P, Alipour F, Jiang S, Sohn J-H, Foulks GN. Optimizing evaluation of Lissamine Green parameters for ocular surface staining. Eye (Lond). 2011;25(11):1429–34.
Haritoglou C, Gandorfer A, Gass CA, Kampik A. Histology of the vitreoretinal interface after staining of the internal limiting membrane using glucose 5% diluted indocyanine green and infracyanine green. Am J Ophthalmol. 2004;137:345–8.
Jackson TL. http://www.opsweb.org/?page=FA.
Jackson TL, Vote B, Knight BC, El-Amir A, Stanford MR, Marshall J. Safety testing of infracyanine green using retinal pigment epithelium and glial cell cultures. Invest Ophthalmol Vis Sci. 2004;45(10):3697–703.
Jacobs J. Fluorescein sodium – what is it? J Ophthalmic Photography. 1992;14:62.
John T. Use of indocyanine green in deep lamellar endothelial keratoplasty. J Cataract Refract Surg. 2003;29(3):437–43.
Kim J. The use of vital dyes in corneal disease. Curr Opin Ophthalmol. 2000;11:241–7.
Kobayashi A, Saeki A, Nishimura A, et al. Visualization of conjunctival cyst by indocyanine green. Am J Ophthalmol. 2002;133(2):827–8.
Kothari K, Jain SS, Shah NJ. Anterior capsular staining with trypan blue for capsulorhexis in mature and hypermature cataracts. A preliminary study. Indian J Ophthalmol. 2001;49(3):177–80.
Laperche Y, Oudea MC, Lostanlen D. Toxic effects of indocyanine green on rat liver mitochondria. Toxicol Appl Pharmacol. 1977;41(2):377–87.
Lass JH, Spurney RV, Rm D, et al. A morphologic and fluorophotometric analysis of the corneal endothelium in type I diabetes mellitus and cystic fibrosis. Am J Ophthalmol. 1985;100:783–8.
Machado LM, Castro RS, Fontes BM. Staining patterns in dry eye syndrome: rose Bengal versus lissamine green. Cornea. 2009;28(7):732–4.
Mao X, Zhang S, Hen H, Du L, Li G, Li B, Zhang H. Corneal permeability assay of topical eye drop solutions in rabbits by MRI. J Huazhong Univ Sci Technolog Med Sci. 2010;30(6):804–8.
Marsh RJ, Fraunfelder FT, McGill JI. Herpetic corneal epithelial disease. Arch Ophthalmol. 1976;94:1899–902.
Mishima A, Gasset A, Klyce Jr SD, Baum JL. Determination of tear volume and tear flow. Invest Ophthalmol. 1966;5:264–76.
Montavale. Physicians’ desk reference for ophthalmic medicines montvale. Thompson PDR; 207, 2006.
Morgan HP, McNae IW, Nowicki MW, Zhong W, Michels PA, Auld DS, Fothergill-Gilmore LA, Walkinshaw MD. The trypanocidal drug suramin and other trypan blue mimetics are inhibitors of pyruvate kinases and bind to the adenosine site. J Biol Chem. 2011;286(36):31232–40.
Morris PF. Fluorescein sodium and indocyanine green: uses and side effects. In: Saine PJ, Tyler ME, editors. Ophthalmic photography: retinal photography, angiography and electronic imaging. 2nd ed. Boston: Butterworth-Heinemann; 2002. p. 137–65.
Narayanan R, Mungcal JK, Kenney MC, et al. Toxicity of triamcinolone acetonide on retinal neurosensory and pigment epithelial cells. Invest Ophthalmol Vis Sci. 2006;47(2):722–8.
Nodarian M, Feys J, Sultan G, Salvanet-Bouccara A. Capsulorhexis staining by trypan blue in mature cataract surgery. J Fr Ophtalmol. 2001;24(3):274–6.
Norn MS. Desiccation of the precorneal tear film. I. Corneal wetting-time. Acta Ophthalmol. 1969;47:865–80.
Peyman GA, Cheema R, Conway MD, Fang T. Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina. 2000;20(5):554–5.
Rodrigues EB, Meyer CH, Farah ME, Kroll P. Intravitreal staining of the internal limiting membrane using indocyanine green in the treatment of macular holes. Ophthalmologica. 2005;219(5):251–62.
Roos JC, Kerr Muir MG. Use of trypan blue for penetrating keratoplasty. J Cataract Refract Surg. 2005;31(10):1867–9.
Saini JS, Jain AK, Sukhija J, et al. Anterior and posterior capsulorhexis in pediatric cataract surgery with or without trypan blue dye: randomized prospective clinical study. J Cataract Refract Surg. 2003;29(9):1733–7.
Satofuka S, Nakamura K, Negishi K, et al. Time course of lens capsule staining using trypan blue and indocyanine green: in vitro study in porcine eyes. J Cataract Refract Surg. 2004;30(8):1751–4.
Sauter JJM. Diagnosis of xerophthalmia by vital staining. Trop Doct. 1976;6:91–3.
Shah GK, Rosenblatt BJ, Smith M. Internal limiting membrane peeling using triamcinolone acetonide: histopathologic confirmation. Am J Ophthalmol. 2004;138(4):656–7.
Stevens A, Altman, Lisa Panders et al. Comparison of trypan blue dye exclusion and flurometric assay for mammalian cell viability. Biotechnol. Prog 1993,9(6 closed up):671–674.
Toczylowska B, Elzbieta Z, Grazyna G, Daniel M, Anna G, Adam L. Neurotoxic effects of indocyanine green -cerebellar granule cell culture viability study Biomed. Opt Express. 2014;5(3):800–16.
Uchiyama E, Aronowicz JD, Butovich IA, Mc Culley JP. Pattern of vital staining and its correlation with aqueous tear deficiency and meibomian gland dropout. Eye Contact Lens. 2007;33(4):177–9.
Wilson II FM. Rose bengal staining of epibulbar squamous neoplasms. Ophthalmic Surg. 1976;7(2):21–3.
Wolfe DR. Fluorescein angiography basic science and engineering. Ophthalmology. 1986;93:1617–20.
Ye YF, Gao YF, Xie HT, Wang HJ.Pharmacokinetics and retinal toxicity of various doses of intravitreal triamcinolone acetonide in rabbits. Mol Vis. 2014;20:629–36.
Yoshikawa T, Hirota S, Ohno Y, Matsumoto S, Ichikawa S, Tomita M, Fukuda T, Sako M, Yokogawa S. Basic study of MR-dacryocystography. Nippon Igaku Hoshasen Gakkai Zasshi. 1998;58(13):758–60.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Saini, M., Nath, M., Vanathi, M. (2016). Ocular Diagnostic Agents. In: Velpandian, T. (eds) Pharmacology of Ocular Therapeutics. Adis, Cham. https://doi.org/10.1007/978-3-319-25498-2_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-25498-2_13
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-25496-8
Online ISBN: 978-3-319-25498-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)